Document is current
Any future updates will be listed below
-
Authors
Sihag, Saurabh
Naze, Sébastien https://orcid.org/0000-0003-0367-402X
Taghdiri, Foad
Gumus, Melisa https://orcid.org/0000-0003-2478-2572
Tator, Charles
Green, Robin
Colella, Brenda
Blennow, Kaj https://orcid.org/0000-0002-1890-4193
Zetterberg, Henrik https://orcid.org/0000-0003-3930-4354
Dominguez, Luis Garcia
Wennberg, Richard https://orcid.org/0000-0002-1865-2280
Mikulis, David J.
Tartaglia, Maria C. https://orcid.org/0000-0002-5944-8497
Kozloski, James R. https://orcid.org/0000-0003-3420-4688
-
Funding
Funding for this research was provided by:
ASNR | Foundation of the American Society of Neuroradiology
Center for Aging and Brain Health Innovation, Baycrest and Canadian federal and provincial govts
- License Information
-
More Information
Article History
Received: 16 November 2020
Accepted: 7 December 2021
First Online: 17 January 2022
Competing interests
: The authors declare the following competing interests: MCT has served as at advisory board for Biogen, Denali, and Roche. KB has served as a consultant, at advisory boards, or at data monitoring committees for Abcam, Axon, Biogen, JOMDD/Shimadzu, Julius Clinical, Lilly, MagQu, Novartis, Roche Diagnostics, and Siemens Healthineers, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (all outside the present paper). HZ has served at scientific advisory boards for Denali, Roche Diagnostics, Wave, Samumed, Siemens Healthineers, Pinteon Therapeutics and CogRx, has given lectures in symposia sponsored by Fujirebio, Alzecure and Biogen, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). All other authors do not have any competing interests to declare.
